Trump Announces Proposals to Make I.V.F. More Affordable
The president unveiled several policy proposals on Thursday aimed at [...]
In the first opportunity for…
In the first opportunity for industry watchers to compare the [...]
Gilead’s Kite Pharma is doubling…
Gilead’s Kite Pharma is doubling down on in vivo CAR-T, [...]
Results presented by AstraZeneca…
Results presented by AstraZeneca from its phase 3 trial of [...]
Dianthus and Boehringer Ingelheim…
Dianthus and Boehringer Ingelheim headlined the latest round of licensing [...]
With the launch of its first…
With the launch of its first direct-to-patient program, Genentech is [...]
The trials demonstrated the…
The trials demonstrated the benefits of Praxis’ ulixacaltamide in essential [...]
French antibody specialist…
French antibody specialist Adcytherix has added a €105 million ($122 [...]
A Keytruda-based regimen has shown…
A Keytruda-based regimen has shown a statistically significant overall survival [...]
America Is Heavily Reliant on China for Raw Materials in Medicines
A new analysis found that nearly 700 drugs approved for [...]